Impact BioMedical Inc. Announces the Closing of its Initial Public Offering
Inc. (NYSE American: IBO), a company discovering and developing new offerings in human healthcare and wellness, today ...
Impact BioMedical Inc. Announces Pricing of Initial Public Offering
Inc. (NYSE American: IBO), a company discovering and developing new offerings in human healthcare and wellness today ...
Kairos Pharma Closing of $6.2 Million Initial Public Offering
The Company has granted to the underwriters a 45-day option to purchase up to an additional 232,500 shares of common stock at the public offering price of $4.00 per share, less underwriting discounts ...
Fabtech Technologies files DRHP for initial public offering with SEBI
Fabtech Technologies, a pharmaceuticals engineering solutions provider, has filed for an IPO. The IPO will consist of a fresh ...
Kairos Pharma Prices $6.2 Million Initial Public Offering
The gross proceeds from the offering, before deducting underwriting fees and other offering expenses payable by the Company, are expected to be $6.2 million. The offering is expected to close on or ...
Kairos Pharma, Ltd.: Kairos Pharma Closing of $6.2 Million Initial Public Offering
Kairos Pharma, Ltd. ("Kairos Pharma" or the "Company") (NYSE American: KAPA), a clinical stage biopharmaceutical company developing cancer therapeutics ...
Kairos Pharma, Ltd.: Kairos Pharma Prices $6.2 Million Initial Public Offering
Kairos Pharma, Ltd. ("Kairos Pharma" or the "Company"), a clinical stage biopharmaceutical company developing cancer therapeutics designed to reverse cancer ...
TMCnet6d
WallachBeth Capital Announces Closing of Trident Digital Tech Holdings Initial Public Offering
WallachBeth Capital LLC acted as Lead Underwriter for the Offering and Revere Securities LLC acted as the Co-Manager for the ...
Morningstar5d
Zenas BioPharma Announces Pricing of Upsized Initial Public Offering
In addition, Zenas has granted the underwriters a 30-day option to purchase up to an additional 1,985,294 shares of common stock at the initial public offering price, less underwriting discounts ...
Financial Post6d
Zenas BioPharma Announces Pricing of Upsized Initial Public Offering
In addition, Zenas has granted the underwriters a 30-day option to purchase up to an additional 1,985,294 shares of common stock at the initial public offering price, less underwriting discounts and ...